BioTime (BTX)’s Subsidiary LifeMap Sciences Announces Release Of LifeMap Discovery Version 1.5 With GeneAnalytics, A Powerful Gene Expression Analysis Tool
1/17/2014 8:14:57 AM
ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery™ version 1.5 (discovery.lifemapsc.com). LifeMap Discovery™ is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology, disease mechanisms and etiology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by